Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cytokine. 2015 Nov 28;78:51–54. doi: 10.1016/j.cyto.2015.11.021

Table 1.

The MIF -794 CATT5–8 promoter variants correlate with severity of WNV disease.

E (%)
n=73
All Other Disease (%)
n=381
p-value, OR (CI) M+ME (%)
n=204
p-value, OR (CI)
Alleles
5-CATT 29 (19.86%) 194 (25.46%) 0.049 103 (25.25%) 0.042
6-CATT 91 (62.33%) 483 (63.39%) 263 (64.46%)
7-CATT 26 (17.81%) 85 (11.5%) 42 (10.29%)
Groups
7-CATT 26 (17.81%) 85 (11.15%) 0.037, OR 1.73
CI (1.07–2.79)
42 (10.29%) 0.027, OR 1.89 (1.10–3.21)
All Others 120 (82.19%) 677 (88.85%) 366 (89.71%)
Genotype
77-CATT 4 (5.5%) 7 (1.83%) 0.0833 1 (0.5%) 0.0174, 11.94 (1.32–108.70)
All other genotypes 69 (94.5%) 374 (98.2%) 203 (99.5%)
Adjusted for Age/ Gender
0.0084, 21.54 (2.20, 210.90)

In comparing the distribution of different CATT alleles among the different disease manifestations in the cases, the low-expresser 5-CATT allele was less common among encephalitis (E) cases, and the high-expresser 7-CATT allele was more common. This difference was significant comparing encephalitis (E) with all other neuroinvasive disease as well as with meningitis and meningoenceophaltitis alone (M + ME).